The vasoactive peptides bradykinin and kallidin (lysyl-bradykinin) have bee
n implicated in diapedesis, a cellular process by which neutrophils migrate
through endothelial cell gap junctions. The kinin peptides are released fr
om their precursor moiety, kininogen, by the specific action of endoprotein
ases, the kallikreins. Kininogens have been demonstrated on the surface of
neutrophils. and the presence of a competent processing enzyme such as tiss
ue prokallikrein in neutrophils has been postulated, but firm evidence for
this is still lacking, We have raised antibodies to a synthetic peptide tha
t is a sequence copy of the activation segment of human TK and demonstrated
that the anti-peptide antibodies specifically recognized the zymogen but n
ot the active form of kallikrein. Using these anti-peptide antibodies, we s
howed by Western blotting, immunocytochemistry and electron microscopy that
the tissue prokallikrein antigen was localized in neutrophils and their pr
ecursor cells, the myelocytes. We further demonstrated by in sills hybridiz
ation the presence of tissue kallikrein mRNA in the mature neutrophils and
myelocytes. Our findings lend credence to the hypothesis that upon release
and activation, neutrophil-borne TK acts on cell-associated kininogens to t
rigger the release of kinins, which may open endothelial gates for neutroph
il diapedesis.